1 min read

Marcus Evans Evolution Summit May 2023

Meet with Shaheen Limbada, EVP Innovation and Strategy at the Evolution Summit



Marcus Evans Evolution logoThe Evolution Summit is an invitation-only, premium summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Veristat thought-leader Shaheen Limbada, EVP Innovation and Strategy will be meeting with
leading clinical trial executives and innovative suppliers and solution providers during this event. 


Be sure to schedule your meeting while there is time.


DATE: 24 May - 26 May 2023
LOCATION: Encore Boston Harbor | Boston, MA





Shaheen Limbada 
VeristatShaheen Limbada 

Executive Vice President, Innovation and Strategy, Veristat 


Shaheen Limbada is the Executive Vice President of Innovation and Strategy of Veristat. In this role, Shaheen oversees identifying and building strategic, innovative solutions to advance the clinical development goals of our clients. With over 22 years of experience running clinical trials, he excels in innovative clinical trial solutions, clinical trial execution, business strategy and business growth. He will initially be focused on applying his skills to enhance and build Veristat's pharmacovigilance, commercialization, and decentralized clinical trial solutions. 
Shaheen spent four years as the Executive Vice President of Global Clinical Operations at Veristat, where he fully integrated new processes for adopting digital and virtual components to improve the patient experience of participating in clinical trials. He joined Veristat through the acquisition of Topstone Research, a Canadian-based CRO he co-founded, and held the position of Managing Director. Before Topstone, he worked in clinical operations, project management, and leadership roles at various clinical research organizations (CROs) and pharmaceutical firms, including Leo Pharma, Cetero Research, and AstraZeneca. 
Mr. Limbada graduated from the University of Toronto and quickly began his career in clinical trials with AstraZeneca Canada Inc. 


Learn More


Share This Event:


1 min read

Chief Medical Officer Summit -CMO 360°

Meet the Veristat team at Booth #3, April 17th and 18th in Boston

The Science-First CRO™ and Consultancy Ready to...

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...